Enzymology in Drug Discovery

Enzymes are the macromolecular and micromolecular proteins in the drug design that act as drug targets for the diseases in the process of discovery of drugs as well as its development. There are a number of drug targets which are involved in the designing of the drugs. Drug target is a nucleic acid or a protein whose activity can be modified by a drug itself. The drug can be a chemical compound with a small molecular weight or a biological compound, such as an antibody or a recombinant protein. The drug target should be effective in the disease by relevant in vitro or in vivo models and analysis.

  • Drug designing using enzymes
  • Drug development using enzymes
  • Drug modelling
  • Drug targeting

Related Conference of Enzymology in Drug Discovery

September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018 |

4th International Conference on Biochemistry & Metabolomics

Los Angeles, California, USA
October 11-12, 2018

13th International Conference on Metabolomics and Systems Biology

Hilton Zurich Airport Hohenbuehlstrasse 10, 8152, Opfikon, Switzerland
October 18-19, 2018

10th International Congress on Structural Biology

Helsinki, Finland
November 19-20, 2018

15th World Congress on

Structural Biology

Paris, France
February 28-March 01, 2019

5th International Conference on Enzymology and Protein Chemistry

Berlin, Germany
July 31-August 01, 2019

6th International Conference on Glycobiology & Glycoproteomics

Chicago, Illinois, USA

Enzymology in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in